Novartis AG Stock price

Equities

NOVN

CH0012005267

Pharmaceuticals

Real-time Estimate Cboe Europe 12:20:00 2024-03-28 pm EDT 5-day change 1st Jan Change
87.26 CHF +0.69% Intraday chart for Novartis AG +0.63% +2.83%
Sales 2024 * 48.14B 43.58B Sales 2025 * 50.19B 45.43B Capitalization 210B 190B
Net income 2024 * 10.05B 9.09B Net income 2025 * 11.03B 9.99B EV / Sales 2024 * 4.59 x
Net Debt 2024 * 11.49B 10.4B Net Debt 2025 * 10.14B 9.17B EV / Sales 2025 * 4.38 x
P/E ratio 2024 *
18.6 x
P/E ratio 2025 *
16.5 x
Employees 76,057
Yield 2024 *
3.9%
Yield 2025 *
4.03%
Free-Float 81.95%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Novartis AG

1 day+0.59%
1 week+0.55%
Current month-2.56%
1 month-3.11%
3 months+3.76%
6 months-6.95%
Current year+2.75%
More quotes
1 week
85.85
Extreme 85.85
87.35
1 month
84.79
Extreme 84.79
91.06
Current year
84.79
Extreme 84.79
94.52
1 year
82.72
Extreme 82.72
94.77
3 years
72.84
Extreme 72.84
94.77
5 years
65.09
Extreme 65.09
96.38
10 years
65.09
Extreme 65.09
103.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 04-12-31
Director of Finance/CFO 59 02-12-31
Chief Tech/Sci/R&D Officer 62 22-05-15
Members of the board TitleAgeSince
Director/Board Member 62 12-12-31
Director/Board Member 65 20-02-27
Chairman 68 12-12-31
More insiders
Date Price Change Volume
24-03-28 87.27 +0.70% 1 589 352
24-03-27 86.66 +0.59% 2,823,832
24-03-26 86.15 -0.30% 2,390,891
24-03-25 86.41 -0.12% 1,801,019
24-03-22 86.51 -0.24% 2,157,126

Delayed Quote Swiss Exchange, March 28, 2024 at 08:45 am EDT

More quotes
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical products (81.7%): used to treat cardiovascular, respiratory, and dermatological diseases, gastrointestinal disorders, cancers, central nervous system disorders, hormone imbalances, etc.; - generic drugs (18.3%; Sandoz). Net sales are distributed geographically as follows: Europe (36.5%), the United States (34.9%), Asia/Africa/Australasia (20.9%), Canada and Latin America (7.7%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
95.72 USD
Average target price
108.4 USD
Spread / Average Target
+13.23%
Consensus
  1. Stock
  2. Equities
  3. Stock Novartis AG - Swiss Exchange